Document is current
Any future updates will be listed below
-
Authors
Taylor, Samuel J.
Stauber, Jacob http://orcid.org/0000-0002-9410-8527
Bohorquez, Oliver
Tatsumi, Goichi
Kumari, Rajni
Chakraborty, Joyeeta
Bartholdy, Boris A.
Schwenger, Emily
Sundaravel, Sriram
Farahat, Abdelbasset A.
Wheat, Justin C.
Goldfinger, Mendel
Verma, Amit
Kumar, Arvind
Boykin, David W.
Stengel, Kristy R.
Poon, Gregory M. K. http://orcid.org/0000-0001-5107-9458
Steidl, Ulrich http://orcid.org/0000-0002-9458-1795
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253127)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL155178)
National Science Foundation (MCB2028902)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM142213)
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 14 August 2024
First Online: 18 September 2024
Competing interests
: U.S. has received research funding from GlaxoSmithKline, Bayer Healthcare, Aileron Therapeutics and Novartis; has received compensation for consultancy services and for serving on scientific advisory boards from GlaxoSmithKline, Bayer Healthcare, Celgene, Aileron Therapeutics, Stelexis Therapeutics and Pieris Pharmaceuticals; and has equity ownership in and is serving on the board of directors of Stelexis Therapeutics. The other authors declare no competing interests.
